Goutham Narla

7.9k total citations
108 papers, 5.3k citations indexed

About

Goutham Narla is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Goutham Narla has authored 108 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 21 papers in Genetics and 19 papers in Oncology. Recurrent topics in Goutham Narla's work include Kruppel-like factors research (43 papers), Cancer-related gene regulation (33 papers) and Genetic Syndromes and Imprinting (16 papers). Goutham Narla is often cited by papers focused on Kruppel-like factors research (43 papers), Cancer-related gene regulation (33 papers) and Genetic Syndromes and Imprinting (16 papers). Goutham Narla collaborates with scholars based in United States, Spain and China. Goutham Narla's co-authors include Scott L. Friedman, John A. Martignetti, Jaya Sangodkar, Analisa DiFeo, Helen L. Reeves, Matthew D. Galsky, Caroline Farrington, Caitlin M. O’Connor, Andrew M. Chan and David B. Kastrinsky and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Goutham Narla

103 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Goutham Narla United States 44 4.2k 994 851 658 428 108 5.3k
David O. Azorsa United States 27 2.6k 0.6× 584 0.6× 1.3k 1.5× 769 1.2× 339 0.8× 58 4.0k
Holger Hebestreit United Kingdom 14 3.4k 0.8× 3.4k 3.4× 850 1.0× 488 0.7× 462 1.1× 17 5.7k
Michal Safran Israel 31 2.4k 0.6× 954 1.0× 434 0.5× 338 0.5× 196 0.5× 46 3.6k
Hiroya Asou Japan 29 2.3k 0.6× 839 0.8× 342 0.4× 1.2k 1.8× 869 2.0× 70 3.9k
Donald Ogilvie United Kingdom 31 2.6k 0.6× 501 0.5× 859 1.0× 1.3k 2.0× 258 0.6× 82 4.5k
Peter Bugert Germany 32 2.1k 0.5× 1.1k 1.1× 443 0.5× 479 0.7× 436 1.0× 147 3.8k
Jiong Deng China 30 3.3k 0.8× 1.2k 1.2× 372 0.4× 2.0k 3.0× 177 0.4× 61 4.8k
Ante S. Lundberg United States 17 3.0k 0.7× 545 0.5× 470 0.6× 1.7k 2.6× 243 0.6× 39 4.7k
Brian C. Lewis United States 33 3.2k 0.8× 1.3k 1.3× 518 0.6× 1.2k 1.8× 107 0.3× 53 4.4k
Sarki A. Abdulkadir United States 38 2.6k 0.6× 881 0.9× 302 0.4× 1.2k 1.9× 176 0.4× 93 4.4k

Countries citing papers authored by Goutham Narla

Since Specialization
Citations

This map shows the geographic impact of Goutham Narla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goutham Narla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goutham Narla more than expected).

Fields of papers citing papers by Goutham Narla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goutham Narla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goutham Narla. The network helps show where Goutham Narla may publish in the future.

Co-authorship network of co-authors of Goutham Narla

This figure shows the co-authorship network connecting the top 25 collaborators of Goutham Narla. A scholar is included among the top collaborators of Goutham Narla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goutham Narla. Goutham Narla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lum, Michelle A., Surendra Parmar, Adrian R. Black, et al.. (2025). Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells. Journal of Clinical Investigation. 135(4).
2.
Ames, Elizabeth G., Shane C. Quinonez, Anthony Scott, et al.. (2025). Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program. Journal of the Endocrine Society. 9(8). bvaf091–bvaf091.
3.
Huang, Wei, Derek J. Taylor, Sarah E. Taylor, et al.. (2024). Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer. Cancer Research. 85(3). 442–461. 3 indexed citations
4.
Mall, G., Alisha Dhiman, Isabel A. English, et al.. (2024). KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development. Oncogene. 43(50). 3673–3687. 2 indexed citations
5.
Qiu, Zhaojun, Yujie Liu, Nigel Bean, et al.. (2024). Low PPP2R2A expression promotes sensitivity to CHK1 inhibition in high-grade serous ovarian cancer. Theranostics. 14(19). 7450–7469. 1 indexed citations
6.
Bailey, Christopher M., Rena G. Lapidus, Sandrine Niyongere, et al.. (2021). PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation. Molecular Cancer Therapeutics. 20(4). 676–690. 17 indexed citations
7.
Qiu, Zhaojun, Tao Liu, E. Ricky Chan, et al.. (2020). A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors. Cancer Research. 80(16). 3305–3318. 26 indexed citations
8.
Rasool, Reyaz ur, Ramakrishnan Natesan, Qu Deng, et al.. (2019). CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation. Cancer Discovery. 9(11). 1538–1555. 86 indexed citations
9.
Taylor, Sarah E., Caitlin M. O’Connor, Zhizhi Wang, et al.. (2019). The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis. Cancer Research. 79(16). 4242–4257. 42 indexed citations
10.
Noto, Fallon K., Kameswaran Ravichandran, Wei Zhang, et al.. (2018). Sprague Dawley Rag2 -Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts. Molecular Cancer Therapeutics. 17(11). 2481–2489. 15 indexed citations
11.
Allen-Petersen, Brittany L., Tyler Risom, Zipei Feng, et al.. (2018). Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma. Cancer Research. 79(1). 209–219. 62 indexed citations
12.
Mallipattu, Sandeep K., Vivette D. D’Agati, Goutham Narla, et al.. (2015). Krüppel-like factor 6 regulates mitochondrial function in the kidney. Journal of Clinical Investigation. 125(3). 1347–1361. 65 indexed citations
13.
Dermawan, Josephine Kam Tai, Katerina V. Gurova, John J. Pink, et al.. (2014). Quinacrine Overcomes Resistance to Erlotinib by Inhibiting FACT, NF-κB, and Cell-Cycle Progression in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 13(9). 2203–2214. 55 indexed citations
14.
Sangodkar, Jaya, Neil S. Dhawan, Rui Yuan, et al.. (2012). Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response. Journal of Clinical Investigation. 122(7). 2637–2651. 70 indexed citations
15.
Vetter, Diana, Michal Cohen‐Naftaly, Augusto Villanueva, et al.. (2012). Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing. Hepatology. 56(4). 1361–1370. 30 indexed citations
16.
Sangodkar, Jaya, et al.. (2010). Lung Adenocarcinoma: Lessons in Translation from Bench to Bedside. Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine. 77(6). 597–605. 34 indexed citations
17.
DiFeo, Analisa, Fei Huang, Jaya Sangodkar, et al.. (2009). KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model. Cancer Research. 69(11). 4733–4741. 38 indexed citations
18.
Sangodkar, Jaya, Analisa DiFeo, Rachel Schwartz, et al.. (2008). Functional role of the KLF6 tumour suppressor gene in gastric cancer. European Journal of Cancer. 45(4). 666–676. 47 indexed citations
19.
Lemmer, Eric R., Ying‐Bei Chen, Steven Yea, et al.. (2006). Dysregulation of hedgehog pathway signaling in hepatocellular carcinoma. Cancer Research. 66. 630–630.
20.
Li, Dan, Steven Yea, SiDe Li, et al.. (2005). Krüppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1. Journal of Biological Chemistry. 280(29). 26941–26952. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David O. Azorsa Breakdown of academic impact, for papers by Holger Hebestreit Breakdown of academic impact, for papers by Michal Safran Breakdown of academic impact, for papers by Hiroya Asou Breakdown of academic impact, for papers by Donald Ogilvie Breakdown of academic impact, for papers by Peter Bugert Breakdown of academic impact, for papers by Jiong Deng Breakdown of academic impact, for papers by Ante S. Lundberg Breakdown of academic impact, for papers by Brian C. Lewis Breakdown of academic impact, for papers by Sarki A. Abdulkadir
Rankless by CCL
2026